SCHEMBL4043697

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3098370	0.90	MAPK14 (0.68)	MAPK14AKR1B1NR3C2
	SCHEMBL15766737	0.89	MAPK14 (0.51)	MAPK14AKR1B1NR3C2
	SCHEMBL15782103	0.89	MAPK14 (0.52)	MAPK14
	SCHEMBL14559426	0.89	MAPK14 (0.60)	MAPK14AKR1B1NR3C2
	SCHEMBL10555531	0.88	MAPK14 (0.60)	MAPK14AKR1B1NR3C2
	SCHEMBL10554226	0.88	ALDH1A1 (0.53)	MAPK14
	SCHEMBL1919447	0.79	APP (0.47)	MAPK14
	SCHEMBL365201	0.78	MAPT (0.61)	—
	SCHEMBL1924055	0.78	MAOB (0.54)	MAPK14NR3C2
	SCHEMBL31621082	0.78	MAPT (0.61)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.